- Home
- EHAB vs VERV Comparison
EHAB vs VERV Comparison
Compare EHAB & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHAB
- VERV
- Stock Information
- Founded
- EHAB 2014
- VERV 2018
- Country
- EHAB United States
- VERV United States
- Employees
- EHAB N/A
- VERV N/A
- Industry
- EHAB Hospital/Nursing Management
- VERV Medicinal Chemicals and Botanical Products
- Sector
- EHAB Health Care
- VERV Health Care
- Exchange
- EHAB Nasdaq
- VERV Nasdaq
- Market Cap
- EHAB 397.2M
- VERV 382.5M
- IPO Year
- EHAB N/A
- VERV 2021
- Fundamental
- Price
- EHAB $7.35
- VERV $4.79
- Analyst Decision
- EHAB Hold
- VERV Strong Buy
- Analyst Count
- EHAB 6
- VERV 4
- Target Price
- EHAB $9.15
- VERV $25.75
- AVG Volume (30 Days)
- EHAB 402.1K
- VERV 1.4M
- Earning Date
- EHAB 11-06-2024
- VERV 11-05-2024
- Dividend Yield
- EHAB N/A
- VERV N/A
- EPS Growth
- EHAB N/A
- VERV N/A
- EPS
- EHAB N/A
- VERV N/A
- Revenue
- EHAB $1,037,200,000.00
- VERV $24,396,000.00
- Revenue This Year
- EHAB $2.55
- VERV $84.66
- Revenue Next Year
- EHAB $3.63
- VERV N/A
- P/E Ratio
- EHAB N/A
- VERV N/A
- Revenue Growth
- EHAB N/A
- VERV 219.91
- 52 Week Low
- EHAB $6.85
- VERV $4.31
- 52 Week High
- EHAB $11.74
- VERV $19.34
- Technical
- Relative Strength Index (RSI)
- EHAB 45.67
- VERV 32.80
- Support Level
- EHAB $6.93
- VERV $6.02
- Resistance Level
- EHAB $8.09
- VERV $6.68
- Average True Range (ATR)
- EHAB 0.35
- VERV 0.47
- MACD
- EHAB 0.02
- VERV -0.14
- Stochastic Oscillator
- EHAB 35.71
- VERV 0.25
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.